Rapid Micro Biosystems (NASDAQ:RPID – Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.22) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02), Zacks reports. Rapid Micro Biosystems had a negative net margin of 145.56% and a negative return on equity of 177.04%.
Rapid Micro Biosystems Stock Performance
Shares of RPID stock traded up $0.08 during trading on Monday, reaching $0.73. 3,554,512 shares of the company’s stock were exchanged, compared to its average volume of 240,740. Rapid Micro Biosystems has a twelve month low of $0.58 and a twelve month high of $4.94. The firm’s fifty day moving average price is $0.92 and its 200-day moving average price is $2.08. The company has a quick ratio of 1.51, a current ratio of 2.55 and a debt-to-equity ratio of 1.08. The stock has a market capitalization of $36.87 million, a PE ratio of -0.66 and a beta of 1.52.
Wall Street Analysts Forecast Growth
A number of brokerages have recently issued reports on RPID. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rapid Micro Biosystems in a report on Thursday, October 15th. Roth Capital started coverage on Rapid Micro Biosystems in a report on Tuesday, September 29th. They set a “buy” rating and a $3.00 price target for the company. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Rapid Micro Biosystems currently has an average rating of “Moderate Buy” and an average target price of $5.00.
Get Our Latest Stock Report on RPID
About Rapid Micro Biosystems
Rapid Micro Biosystems develops automated microbial detection systems for pharmaceutical, biotechnology and other life sciences manufacturers. Its products are designed to support quality-control testing by identifying and measuring microbial growth in manufacturing environments and products. The company’s Growth Direct platform combines laboratory instruments, consumables and software to automate microbial testing. Its applications include sterility testing, bioburden testing and environmental monitoring, helping manufacturers assess contamination during production.
Read More
- Five stocks we like better than Rapid Micro Biosystems
- Could Big Buybacks Be the Next Catalyst for These 3 AI Stocks?
- 3 AI Hardware Leaders Are Raising Dividends, But Which Offers More Income?
- Sandisk’s Sell-Off May Be Losing Steam, But the Biggest Risk Still Looms
- Meta’s Access to Capital Remains Strong, But Borrowing Is Becoming More Expensive
Receive News & Ratings for Rapid Micro Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rapid Micro Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
